Bempedoic Acid
1 NDC across 1 manufacturer|0 Generic,1 Brand
Bempedoic Acid is used to treat atherosclerosis and hyperlipoproteinemia type II, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 21, 2020. In 2024, Medicare Part D spent $71 million on Bempedoic Acid across 100,000 claims for 30,000 beneficiaries.
Bempedoic Acid is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $13.81 to $13.81 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$13.81 – $13.81
per EA
7d Activity
avg -0.1% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing BEMPEDOIC ACID
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
NEXLETOL 180 MG TABLET | $13.8056 per EA | -0.05% |
Frequently Asked Questions
What is Bempedoic Acid used to treat?
Bempedoic Acid is used to treat atherosclerosis and hyperlipoproteinemia type II, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Bempedoic Acid?
In 2024, Medicare Part D spent $71 million on Bempedoic Acid across 100,000 claims for 30,000 beneficiaries.
How many Bempedoic Acid products are on the market?
The Bempedoic Acid drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Bempedoic Acid?
NADAC reference prices for Bempedoic Acid range from $13.8056 to $13.8056 per EA.
Which manufacturers make Bempedoic Acid?
1 manufacturer lists Bempedoic Acid in NADAC. Ranked by number of NDCs, the largest are Esperion Therapeutics, Inc. (1).
How has the price of Bempedoic Acid changed recently?
Over the past 7 days, 0 Bempedoic Acid NDCs rose and 1 fell, with a market-wide average change of -0.1%.